Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

Actavis plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company was founded on October 1, 2013 and is... 
02/17Earnings Release
Surperformance© rating of Actavis Inc
Trading Rating : Investor Rating :
More about the company
Financials ($)
Sales 2014 12 643 M
EBIT 2014 3 797 M
Net income 2014 1 188 M
Debt 2014 15 045 M
Yield 2014 -
Sales 2015 15 535 M
EBIT 2015 5 573 M
Net income 2015 2 968 M
Debt 2015 10 196 M
Yield 2015 -
PER 2014 137,43
PER 2015 22,48
EV / Sales 2014 6,64x
EV / Sales 2015 5,09x
Capitalization 68 850 M
More Financials
Latest news on ACTAVIS INC
3d ago Valeant slashes stake in Allergan after losing bid
3d ago Global M&A lending hits post-crisis high
3d ago Global M&A deals cross $3 trillion for first time since 2007
4d ago Valeant slashes stake in Allergan after losing bid
4d ago Valeant Pharma says may buy back up to $2 billion worth of securities
4d agoDJValeant Sets $2 Billion Buyback Plan After Losing Allergan
5d agoDJFor Allergan Suitors, Unorthodox Alliance Proved Unwieldy
6d agoDJGoldman Hits Mother Lode on Deals
6d agoDJAckman Drops Push for Allergan Holder Meeting--2nd Update
6d agoDJWILLIAM ACKMAN : Ackman Drops Push for Allergan Holder Meeting--Update
6d ago WALL STREET STOCK EXCHANGE : S&P 500, Dow end at record highs, boosted by health..
6d agoDJMARKET SNAPSHOT : S&P, Dow Ring Up Records Tuesday
More news
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes